凯里集团扩大科克生物技术设施,以满足全球无乳糖奶制品需求. Kerry Group expands Cork biotech facility to meet global lactose-free dairy demand.

为了满足全球对无乳糖奶制品需求的不断增长,克里集团扩大了位于科尔克州卡利加林 (Carrigaline) 的生物技术生产设施. Kerry Group has expanded its biotechnology manufacturing facility in Carrigaline, Cork, to meet rising global demand for lactose-free dairy products. 这项投资将增加乳糖酶生产能力,支持80个国家的200多家客户,并为估计的2800万消费者提供服务. The investment boosts production capacity for lactase enzymes, supporting over 200 customers across 80 countries and serving an estimated 28 million consumers. 官员们赞扬该项目,因为它促进了爱尔兰在高价值生物技术制造业中的作用. Officials praised the project for advancing Ireland's role in high-value biotechnology manufacturing.